BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01520519-completion@plaintrial.com
DTSTAMP:20260928T182131Z
DTSTART;VALUE=DATE:20180809
SUMMARY:Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibi
 tor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and 
 Small Lymphocytic Lymphoma Patients — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01520519
URL:https://plaintrial.com/trial/NCT01520519
END:VEVENT
END:VCALENDAR